Q

QuidelOrtho Corp
D

QDEL

34.070
USD
-0.90
(-2.57%)
Market Closed
Volume
0
EPS
2
Div Yield
-
P/E
-1
Market Cap
2,297,903,754
Related Instruments
ABT
ABT
-1.000
(-0.75%)
131.670 USD
BDX
BDX
-3.060
(-1.34%)
226.010 USD
C
CRL
-4.560
(-3.03%)
146.000 USD
DGX
DGX
0.170
(0.10%)
169.270 USD
DHR
DHR
-4.610
(-2.25%)
200.360 USD
HOLX
HOLX
-0.410
(-0.66%)
61.360 USD
ILMN
ILMN
-0.990
(-1.25%)
78.340 USD
LH
LH
-0.130
(-0.06%)
232.510 USD
TMO
TMO
-14.74
(-2.96%)
482.93 USD
More
News

Title: QuidelOrtho Corp

Sector: Healthcare
Industry: Medical Devices
QuidelOrtho Corp is engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if its revenue from North America.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.